Vanberra Signal

Transdermal Diagnostics

Curated by Signal

Provider of a needle-free continuous glucose monitoring device

Overview

Provider of a needle-free continuous glucose monitoring device. The company offers a disposable adhesive skin patch and rechargeable transmitter for non-invasive monitoring of chronic conditions, starting with diabetes.

Key facts

Founded
2021

Business model

Contact

Open roles

1 role
  • Bioelectronics Engineer – Wearable MedTech Platform

    City Of Bristol, England, United Kingdom · On-site · Full-time

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Developer of electrochemical biosensing technology for redefining diagnostics

    Life Sciences TechnologyGlasgow, United Kingdom
  • Vertical turbine technology based spirometers

    Life Sciences TechnologyKent, United Kingdom
  • Blood glucose meter

    Life Sciences TechnologyGodmanchester, United Kingdom

About Transdermal Diagnostics

What does Transdermal Diagnostics do?

Provider of a needle-free continuous glucose monitoring device.

Where is Transdermal Diagnostics headquartered?

Transdermal Diagnostics is headquartered in Bath, United Kingdom.

When was Transdermal Diagnostics founded?

Transdermal Diagnostics was founded in 2021.

Which sector is Transdermal Diagnostics in?

Transdermal Diagnostics operates in Life Sciences Technology.

Who are Transdermal Diagnostics's competitors?

Companies similar to Transdermal Diagnostics include AureumDx, MedChip Solutions, and Microdot.

Is Transdermal Diagnostics hiring?

Yes. Transdermal Diagnostics has 1 open role listed on Vanberra Signal.